Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

68 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Treatment of antipsychotic-associated obesity with a GLP-1 receptor agonist--protocol for an investigator-initiated prospective, randomised, placebo-controlled, double-blinded intervention study: the TAO study protocol.
Ishøy PL, Knop FK, Broberg BV, Baandrup L, Fagerlund B, Jørgensen NR, Andersen UB, Rostrup E, Glenthøj BY, Ebdrup BH. Ishøy PL, et al. Among authors: andersen ub. BMJ Open. 2014 Jan 8;4(1):e004158. doi: 10.1136/bmjopen-2013-004158. BMJ Open. 2014. PMID: 24401727 Free PMC article. Clinical Trial.
Effect of GLP-1 receptor agonist treatment on body weight in obese antipsychotic-treated patients with schizophrenia: a randomized, placebo-controlled trial.
Ishøy PL, Knop FK, Broberg BV, Bak N, Andersen UB, Jørgensen NR, Holst JJ, Glenthøj BY, Ebdrup BH. Ishøy PL, et al. Among authors: andersen ub. Diabetes Obes Metab. 2017 Feb;19(2):162-171. doi: 10.1111/dom.12795. Epub 2016 Nov 14. Diabetes Obes Metab. 2017. PMID: 27717222 Free PMC article. Clinical Trial.
Erratum: Effect of GLP-1 receptor agonist treatment on body weight in obese antipsychotic-treated patients with schizophrenia: A randomized, placebo-controlled trial.
Ebdrup BH, Broberg BV, Ishøy PL, Bak N, Andersen UB, Jørgensen NR, Holst JJ, Knop FK, Glenthøj BY. Ebdrup BH, et al. Among authors: andersen ub. Diabetes Obes Metab. 2018 May;20(5):1327-1328. doi: 10.1111/dom.13204. Epub 2018 Jan 23. Diabetes Obes Metab. 2018. PMID: 29316175 Free PMC article. No abstract available.
Bone Status in Obese, Non-diabetic, Antipsychotic-Treated Patients, and Effects of the Glucagon-Like Peptide-1 Receptor Agonist Exenatide on Bone Turnover Markers and Bone Mineral Density.
Eriksson R, Broberg BV, Ishøy PL, Bak N, Andersen UB, Jørgensen NR, Knop FK, Ebdrup BH. Eriksson R, et al. Among authors: andersen ub. Front Psychiatry. 2019 Jan 28;9:781. doi: 10.3389/fpsyt.2018.00781. eCollection 2018. Front Psychiatry. 2019. PMID: 30745885 Free PMC article.
68 results